- Home
- HUMA vs EDD Comparison
HUMA vs EDD Comparison
Compare HUMA & EDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- EDD
- Stock Information
- Founded
- HUMA 2004
- EDD 2007
- Country
- HUMA United States
- EDD United States
- Employees
- HUMA N/A
- EDD N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- EDD Finance Companies
- Sector
- HUMA Health Care
- EDD Finance
- Exchange
- HUMA Nasdaq
- EDD Nasdaq
- Market Cap
- HUMA 250.2M
- EDD 329.4M
- IPO Year
- HUMA N/A
- EDD N/A
- Fundamental
- Price
- HUMA $1.51
- EDD $5.30
- Analyst Decision
- HUMA Strong Buy
- EDD
- Analyst Count
- HUMA 8
- EDD 0
- Target Price
- HUMA $10.88
- EDD N/A
- AVG Volume (30 Days)
- HUMA 5.9M
- EDD 254.3K
- Earning Date
- HUMA 08-11-2025
- EDD 01-01-0001
- Dividend Yield
- HUMA N/A
- EDD 7.52%
- EPS Growth
- HUMA N/A
- EDD N/A
- EPS
- HUMA N/A
- EDD N/A
- Revenue
- HUMA $818,000.00
- EDD N/A
- Revenue This Year
- HUMA N/A
- EDD N/A
- Revenue Next Year
- HUMA $949.92
- EDD N/A
- P/E Ratio
- HUMA N/A
- EDD N/A
- Revenue Growth
- HUMA N/A
- EDD N/A
- 52 Week Low
- HUMA $1.15
- EDD $4.22
- 52 Week High
- HUMA $6.77
- EDD $4.95
- Technical
- Relative Strength Index (RSI)
- HUMA 36.87
- EDD 56.10
- Support Level
- HUMA $1.43
- EDD $5.24
- Resistance Level
- HUMA $1.67
- EDD $5.42
- Average True Range (ATR)
- HUMA 0.15
- EDD 0.05
- MACD
- HUMA -0.01
- EDD -0.01
- Stochastic Oscillator
- HUMA 23.32
- EDD 40.00
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.
Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.